Enhanced conjugation stability and blood circulation time of macromolecular gadolinium-DTPA contrast agent

Materials Science and Engineering C

Volumn 61, Issue , 2016, Pages 659-664

  Jenjob, Ratchapol ^a   Kun, Na ^b   Ghee, Jung Yeon ^c   Shen, Zheyu ^d   Wu, Xiaoxia ^d   Cho, Steve K ^f   Lee, Don Haeng ^c,e   Yang, Su Geun ^a  

^a Inha University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Utah Inha DDS and Advanced Theapeutics Research Center   (South Korea)

^d NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING   (China)

^e Inha University Hospital   (South Korea)

^f Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Chelation stability; Extended blood circulation; Gadolinium DTPA; Nephrogenic fibrosis; Transmetalation

Indexed keywords

BLOOD; CALCIUM; CARDIOVASCULAR SYSTEM; CHELATION; DIALYSIS MEMBRANES; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; METAL IONS; METALS; PHYSIOLOGY; PLASMA STABILITY; RATS; STABILITY;

ABDOMINAL IMAGES; BLOOD CIRCULATION; DIETHYLENE TRIAMINE; ENHANCED CONJUGATION; INTRAVENOUS INJECTIONS; NEPHROGENIC FIBROSIS; PLASMA CONCENTRATION; TRANSMETALATION;

GADOLINIUM;

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GLUCAN; PULLULAN;

ANIMAL; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RAT;

ANIMALS; CONTRAST MEDIA; GADOLINIUM DTPA; GLUCANS; MAGNETIC RESONANCE IMAGING; RATS;

EID: 84953807607     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.01.008     Document Type: Article

References (28)

1. P. Caravan, J.J. Ellison, T.J. McMurry, and R.B. Lauffer Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99 1999 2293 2352
2. S.A. Greenberg Zinc transmetallation and gadolinium retention after MR imaging: case report Radiology 257 2010 670 673
3. T. Grobner Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol. Dial. Transplant. 21 2006 1104 1108
4. P. Marckmann, L. Skov, K. Rossen, A. Dupont, M.B. Damholt, J.G. Heaf, and H.S. Thomsen Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J. Am. Soc. Nephrol. 17 2006 2359 2362
5. M.A. Perazella, and R.F. Reilly Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease Semin. Dial. 21 2008 171 173
6. A.D. Sherry, P. Caravan, and R.E. Lenkinski Primer on gadolinium chemistry J. Magn. Reson. Imaging 30 2009 1240 1248
7. K.J. Murphy, J.A. Brunberg, and R.H. Cohan Adverse reactions to gadolinium contrast media: a review of 36 cases AJR Am. J. Roentgenol. 167 1996 847 849
8. M.F. Bellin MR contrast agents, the old and the new Eur. J. Radiol. 60 2006 314 323
9. C.F. Geraldes, and S. Laurent Classification and basic properties of contrast agents for magnetic resonance imaging Contrast Media Mol. Imaging 4 2009 1 23
10. K.N. Raymond, and V.C. Pierre Next generation, high relaxivity gadolinium MRI agents Bioconjug. Chem. 16 2005 3 8
11. M.F. Silva, L.P. Fernandez, and R.A. Olsina Monitoring the elimination of gadolinium-based pharmaceuticals. Cloud point preconcentration and spectrophotometric determination of Gd(III)-2-(3,5-dichloro-2-pyridylazo)-5-dimethylaminophenol in urine Analyst 123 1998 1803-1807
12. M.N. Eakins, S.M. Eaton, R.A. Fisco, R.J. Hunt, C.E. Ita, T. Katona, L.M. Owies, E. Schramm, J.W. Sulner, C.W. Thompson, and et al. Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs Acad. Radiol. 2 1995 584 591
13. Y. Feng, Y. Zong, T. Ke, E.K. Jeong, D.L. Parker, and Z.R. Lu Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model Pharm. Res. 23 2006 1736 1742
14. T. Staks, G. Schuhmann-Giampieri, T. Frenzel, H.J. Weinmann, L. Lange, and J. Platzek Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers Investig. Radiol. 29 1994 709 715
15. C.H. Huang, and A. Tsourkas Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging Curr. Top. Med. Chem. 13 2013 411 421
16. H. Yim, S.G. Yang, Y.S. Jeon, I.S. Park, M. Kim, D.H. Lee, Y.H. Bae, and K. Na The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI Biomaterials 32 2011 5187 5194
17. B. Hamm, T. Staks, A. Muhler, M. Bollow, M. Taupitz, T. Frenzel, K.J. Wolf, H.J. Weinmann, and L. Lange Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 1995 785 792
18. A. Barge, G. Cravotto, E. Gianolio, and F. Fedeli How to determine free Gd and free ligand in solution of Gd chelates. A technical note Contrast Media Mol. Imaging 1 2006 184 188
19. T. Frenzel, P. Lengsfeld, H. Schirmer, J. Hutter, and H.J. Weinmann Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C Investig. Radiol. 43 2008 817 828
20. Z. Jaszberenyi, I. Banyai, E. Brucher, R. Kiraly, K. Hideg, and T. Kalai Equilibrium and NMR studies on GdIII, YIII, CuII and ZnII complexes of various DTPA-N,N″-bis(amide) ligands. Kinetic stabilities of the gadolinium(III) complexes Dalton Trans. 2006 1082 1091
21. W.P. Cacheris, S.C. Quay, and S.M. Rocklage The relationship between thermodynamics and the toxicity of gadolinium complexes Magn. Reson. Imaging 8 1990 467 481
22. H.J. Weinmann, G. Schuhmann-Giampieri, H. Schmitt-Willich, H. Vogler, T. Frenzel, and H. Gries A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI Magn. Reson. Med. 22 1991 233 237 (discussion 242)
23. T. Yamaoka, Y. Tabata, and Y. Ikada Body distribution profile of polysaccharides after intravenous administration Drug Deliv. 1 1993 75 82
24. V.L. Nguyen, M.E. Kooi, W.H. Backes, R.H. van Hoof, A.E. Saris, M.C. Wishaupt, F.A. Hellenthal, R.J. van der Geest, A.G. Kessels, G.W. Schurink, and T. Leiner Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison PLoS One 8 2013 e75173
25. B. Turkbey, D. Thomasson, Y. Pang, M. Bernardo, and P.L. Choyke The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment Diagn. Interv. Radiol. 16 2010 186 192
26. A. Phinikaridou, M.E. Andia, S. Lacerda, S. Lorrio, M.R. Makowski, and R.M. Botnar Molecular MRI of atherosclerosis Molecules 18 2013 14042 14069
27. C. Nolte-Ernsting, G. Adam, A. Bucker, S. Berges, A. Bjornerud, and R.W. Gunther Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer AJR Am. J. Roentgenol. 171 1998 107 113
28. A.J. van der Molen, and M.F. Bellin Extracellular gadolinium-based contrast media: differences in diagnostic efficacy Eur. J. Radiol. 66 2008 168 174